Quality Assurance

Quality controlled to ensure premium products

Bod delivers only the highest quality products to patients that are safe and efficacious. Bod has developed a quality-controlled manufacturing process to ensure it can consistently and reliably deliver on this promise. Our commitment to quality ensures that patients and practitioners can be comfortable and confident in knowing they are receiving a premium product that is consistent and reliable.

Bod’s medicinal cannabis, MediCabilis, has high-quality assurance from plant to product. Bod’s medicinal cannabis products are cultivated and manufactured by the internationally-renowned company Linnea, a licensed Swiss producer of medicinal cannabis and other natural products.

Every part of the process complies with the codes of acceptable manufacturing standards to ensure quality of the medicinal cannabis and ingredients used in the manufacture are of an acceptable standard and safe for the consumer.

Cannabinoid Content

The cannabinoid content of Bod’s products are evaluated regularly to ensure that the cannabinoid content of the products are consistent with the contents declared on the label – which has been confirmed and verified with analytical analysis from a third-party.

Impurities

Each batch of medicinal cannabis products are also regularly evaluated for contaminants using standardised and validates analytical techniques to determine purity.

Safety and Tolerability

Bod’s medicinal cannabis, MediCabilis, has additional assurance of safety and tolerability determined by its successful performance in Phase 1 clinical study.1

Additionally, Bod has now filled over 3000 prescriptions as of May 2020, with continued growth of new and repeated patients using our products.

Production of a well manufactured product and regular quality assessments ensures products are compliant with the Australian Therapeutic Goods Administration’s relevant quality standards, such as the Therapeutic Goods -(Standard for Medicinal Cannabis) (TGO 93) Order 2017.2-3 Bod consistently surpasses the national quality control standards, consistently delivering premium medicinal cannabis product. Patients will receive known and regulated dosing of cannabinoids, whilst also ensuring the absence of toxic and harmful impurities. Our commitment to quality ensures that we are not only providing a premium product but also providing peace of mind.

References

  1. A phase 1 clinical trial was conducted on the MediCabilis 5% CBD full-spectrum oil and the innovation wafer. The study is progressing towards publication, but research can be provided on request in the interim.
  2. https://www.tga.gov.au/access-medicinal-cannabis-products-1
  3. https://www.tga.gov.au/good-manufacturing-practice-overview